Venkata G Meka
Affiliation: Harvard University
- Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNAVenkata G Meka
Division of Infectious Diseases, Department of Medicine, and Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
J Infect Dis 190:311-7. 2004..The most recent isolate of this series was recovered 7 months after the patient discontinued linezolid and demonstrated reversion to a susceptible phenotype associated with a loss of the T2500A mutation...
- Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureusVenkata G Meka
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
J Antimicrob Chemother 54:818-20. 2004..aureus isolate that developed linezolid resistance (MIC of linezolid of 12 mg/L) after a 25 day course of the drug. Sequencing identified G2576T mutations in four of the five copies of the 23S rRNA gene...
- Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal proteinVance G Fowler
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
J Infect Dis 190:1140-9. 2004..This investigation examined potential associations between PB with key clinical features and several in vitro bacterial genotypic and phenotypic characteristics, in isolates from 1 institution...
- Antimicrobial resistance to linezolidVenkata G Meka
Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
Clin Infect Dis 39:1010-5. 2004....
- Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycinChristopher W Woods
Clinical Microbiology, Durham Veterans Administration Medical Center, Durham, NC 27705, USA
Clin Infect Dis 38:1188-91. 2004..We report the strain characterization and treatment of a patient with SARV IE...
- Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplaninMichael J Rybak
Anti Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
Diagn Microbiol Infect Dis 51:119-25. 2005..To our knowledge, this is the earliest report of S. aureus clinical isolates having reduced vancomycin and teicoplanin susceptibility...